Social Prescribing for Advancing Resilience in Kids: A Pilot Study of Social Prescribing
Launched by UNIVERSITY OF OTTAWA · Jun 6, 2025
Trial Information
Current as of August 19, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial, called "Social Prescribing for Advancing Resilience in Kids," is exploring whether a program called Social Prescription (SP) can help improve mental health and overall wellbeing in young people aged 11 to 17. The study aims to find out if this program is easy to use and accepted by youth, their caregivers, and staff in the community. The researchers will compare the SP program to an educational program to see if SP can reduce stress and enhance social connections and mental health in participants.
To participate, young people must be between 11 and 17 years old, on a waitlist for mental health services, and not pose a safety threat to themselves or others. Participants will be randomly assigned to either the SP program or the educational program and will complete surveys about their mental health at the start of the study and again after 12 weeks. They will also share their experiences through interviews after taking part in the SP program. This study is not yet recruiting, but it aims to help improve mental health support for youth in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • between 11-17 years of age
- • on the waitlist for mental health services
- • are not an immediate safety threat to themselves or others as assessed by the HEADS ED questionnaire
- Exclusion Criteria:
- • Children \< 11 years old
- • Adolescents \> 17 years old
About University Of Ottawa
The University of Ottawa, a leading research institution in Canada, is dedicated to advancing healthcare through innovative clinical trials and studies. With a commitment to excellence in research and a robust network of interdisciplinary collaboration, the university leverages its expertise in various medical fields to enhance patient care and public health outcomes. The institution fosters an environment that promotes ethical research practices, ensuring the safety and well-being of participants while contributing to the scientific community's understanding of diverse health issues. Through its clinical trial initiatives, the University of Ottawa aims to translate research findings into tangible benefits for society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ottawa, Ontario, Canada
Patients applied
Trial Officials
Nicole Racine, PhD
Principal Investigator
University of Ottawa
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported